Stock Research: LivaNova

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

LivaNova

NasdaqGS:LIVN GB00BYMT0J19
41
  • Value
    17
  • Growth
    69
  • Safety
    Safety
    44
  • Combined
    26
  • Sentiment
    62
  • 360° View
    360° View
    41
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

LivaNova PLC is a medical technology company. It operates in the medical technology industry, specifically in cardiopulmonary and neuromodulation. LivaNova PLC operates globally. In the last fiscal year, the company had a market cap of $2,368 million, profits of $871 million, revenue of $1,253 million, and 2900 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 41 (better than 41% compared with alternatives), overall professional sentiment and financial characteristics for the stock LivaNova are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for LivaNova. The consolidated Growth Rank has a good rank of 69, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 69% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 62, which means that professional investors are more optimistic about the stock than for 62% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 44, which means that the share price of LivaNova is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 56% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 17, which means that the company has a financing structure that is riskier than those of 83% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
NASDAQ
S&P MIDCAP
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Nov-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
44 30 27 27
Growth
69 26 59 57
Safety
Safety
17 46 54 6
Sentiment
62 56 29 42
360° View
360° View
41 21 27 13
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
79 85 56 83
Opinions Change
94 56 50 50
Pro Holdings
n/a n/a n/a n/a
Market Pulse
11 25 8 2
Sentiment
62 56 29 42
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
44 30 27 27
Growth
69 26 59 57
Safety Safety
17 46 54 6
Combined
26 9 35 8
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
75 13 1 20
Price vs. Earnings (P/E)
53 57 56 48
Price vs. Book (P/B)
53 71 68 59
Dividend Yield
1 1 1 1
Value
44 30 27 27
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
57 37 34 12
Profit Growth
60 55 70 70
Capital Growth
65 34 65 69
Stock Returns
41 30 39 61
Growth
69 26 59 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
46 56 54 36
Refinancing
35 83 73 9
Liquidity
8 12 14 10
Safety Safety
17 46 54 6

Similar Stocks

Discover high‑ranked alternatives to LivaNova and broaden your portfolio horizons.

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Smith & Nephew

LSE:SN.
Country: United Kingdom
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Schroders

LSE:SDR
Country: United Kingdom
Industry: Asset Management & Custody
Size: Large
Full Stock Analysis

Bellway

LSE:BWY
Country: United Kingdom
Industry: Homebuilding
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.